Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J Schnitzer

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Expert Opinion on Pharmacotherapy|October 5, 2001
Update on alendronate for osteoporosis: once-weekly dosingT J Schnitzer
Contemporary Orthopaedics|April 8, 1995
NSAIDs in orthopaedic practice: management guidelines for arthritis patientsT J Schnitzer
The American Journal of Medicine|February 13, 2001
Cyclooxygenase-2--specific inhibitors: are they safe?T J Schnitzer
The Journal of General Virology|March 1, 1982
Simian foamy virus pseudotypes of vesicular stomatitis virus: production and use in sero-epidemiological investigationsT J Schnitzer
The American Journal of Medicine|August 26, 1998
Non-NSAID pharmacologic treatment options for the management of chronic painT J Schnitzer
Virology|February 1, 1985
Protein coding assignment of the S genes of the avian reovirus S1133T J Schnitzer
Clinical Therapeutics|April 25, 2001
Osteoarthritis management: the role of cyclooxygenase-2-selective inhibitorsT J Schnitzer
Postgraduate Medicine|January 1, 1993
Osteoarthritis treatment update. Minimizing pain while limiting patient riskT J Schnitzer
The Journal of General Virology|January 1, 1979
Phenotypic mixing between two primate oncovirusesT J Schnitzer
Journal of Medical Primatology|January 1, 1981
Characterization of a simian foamy virus isolated from a spontaneous primate lymphomaT J Schnitzer
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Expert Opinion on Pharmacotherapy|October 5, 2001
Update on alendronate for osteoporosis: once-weekly dosingT J Schnitzer
Contemporary Orthopaedics|April 8, 1995
NSAIDs in orthopaedic practice: management guidelines for arthritis patientsT J Schnitzer
The American Journal of Medicine|February 13, 2001
Cyclooxygenase-2--specific inhibitors: are they safe?T J Schnitzer
The Journal of General Virology|March 1, 1982
Simian foamy virus pseudotypes of vesicular stomatitis virus: production and use in sero-epidemiological investigationsT J Schnitzer
The American Journal of Medicine|August 26, 1998
Non-NSAID pharmacologic treatment options for the management of chronic painT J Schnitzer
Virology|February 1, 1985
Protein coding assignment of the S genes of the avian reovirus S1133T J Schnitzer
Clinical Therapeutics|April 25, 2001
Osteoarthritis management: the role of cyclooxygenase-2-selective inhibitorsT J Schnitzer
Postgraduate Medicine|January 1, 1993
Osteoarthritis treatment update. Minimizing pain while limiting patient riskT J Schnitzer
The Journal of General Virology|January 1, 1979
Phenotypic mixing between two primate oncovirusesT J Schnitzer
Journal of Medical Primatology|January 1, 1981
Characterization of a simian foamy virus isolated from a spontaneous primate lymphomaT J Schnitzer
Pageof 11